Real-World Effectiveness and Usage of Recombinant Factor IX Fc: Interim Analysis in
Paediatric Patients from the 24-Month, Prospective, Non-Interventional B-MORE Study
Authors
H Glosli
1
Oslo University Hospital, Centre for Rare Disorders, Oslo, Norway
I Wieland
2
Hannover Medical School, Department of Pediatric Hematology and Oncology, Hannover,
Germany
H Pergantou
3
Aghia Sophia Children’s Hospital, Paediatric Haemophilia Centre/Haemostasis and Thrombosis
Unit, Athens, Greece
B Nolan
4
Children's Health Ireland at Crumlin, Children’s Coagulation Centre, Dublin,
Ireland
R Berrueco
5
Sant Joan de Déu Hospital, Pediatric Hematology Department, Barcelona, Spain
S Ranta
6
Karolinska University Hospital, Astrid Lindgren Children’s Hospital, Paediatric Coagulation
Centre, Stockholm, Sweden
M Al Saleh
7
King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
